Life Science Instrumentation Market 2019-2027: Global Industry Growth Size Analysis (6.5% CAGR)

1. Life Science Instrumentation Market: Global Business Analysis (6.5% CAGR) 2019-2027 The recent market report issued by Credence Research, Inc. was valued at US$ 57,185.5 million in 2018 and is anticipated to achieve US$ 100,792.7 million by 2027, increasing to CAGR by 6.5 percent from 2019 to 2027. According to statistics provided by the United Nations Population Division (UNPD), the global death rate in 2017 was 7.6 per 1,000 people, which is dramatically low compared to 17.7 per 1,000 people in 1960. Technological advancements in life science instrumentation techniques have been responsible for the manufacturing of an extremely safe and effective drug molecule for the treatment of chronic diseases and are using technology to provide a promising drug pipeline shortly. The technology segment for life science instrumentation is presently dominated by spectroscopy technology. It is a very ancient and reliable method used by healthcare experts to monitor and validate the quality of drugs. Its intrinsic characteristics, such as ease of sample preparing for quantitative and qualitative drug evaluation and ease of handling, are responsible for growing demand across life science sectors. Due to its wide application in the development of personalized medicine and the ability to create biological sequences for complex molecules at low cost and speed, next-generation sequencing is gaining enormous traction. Full Report on Life Science Instrumentation Market: https://www.credenceresearch.com/report/life- science-instrumentation-market For the life science instrumentation market, pharmaceutical, and biotechnology companies are the biggest market holder in the end-user segment. The burgeoning requirement for novel drugs to treat chronic ailments and a substantial increase in initial throughput screening connected with the inquiry of new drug phase (IND) raises the demand for life science instrumentation technology in pharmaceutical and biotechnology businesses. Diagnostic laboratories are eager to record remarkable development in the near future due to increased awareness of public health leading to early diagnosis of disease. Infectious and chronic disease diagnosis is one of Life Science instrumentation’s leading applications. The emergence and outbreak of multiple infectious diseases have produced difficulties for researchers and new possibilities to create diagnostic devices and tests for early diagnosis and disease prevention. According to the WHO World Health Report, infectious diseases account for around 17 million fatalities worldwide every year. Also, the emergence of new illnesses has risen in recent years. Several countries have not invested properly to control common infectious diseases, according to reports. This improves the demand for early detection diagnostic tools to avoid infectious disease outbreaks. This factor is expected to boost the growth of the worldwide market for life science tools during the forecast period. Increase in R&D operations in the biotechnology and pharmaceutical sectors. The pharmaceutical and biotechnology sectors are diverting important assets to R&D operations. This is due to increased demand for fast drug development and the commercialization of novel drug molecules for the therapy of multiple rare diseases. The pharmaceutical industry spends approximately US$ 150 billion annually on R&D, according to the International Federation of Pharmaceutical Manufacturers and Association (IFPMA). In 2015, 56 new drugs were launched and more than 7000 new compounds were being developed. Also, the number of new drugs developed has increased significantly, and these have been launched in the last few years. Drug development in diseases such as cancer, cardiovascular disease,

2. neurological and infectious diseases has increased globally. This creates a demand for efficient and fast life science instruments to speed up the process. This acts during the forecast period as a major driver for the global life science instrumentation market. Full Report on Life Science Instrumentation Market: https://www.credenceresearch.com/report/life- science-instrumentation-market Report Scope by Segments The market segmentation for the scope of the report is done as by technology, end-user and geography. By Technology (2017-2027; US$ Mn) Spectroscopy  Chromatography  Polymerase Chain Reaction  Next-Generation Sequencing  Clinical Chemistry Analyzers  Flow Cytometry  Immunoassays  By End User (2017-2027; US$ Mn) Research Institutes  Pharmaceutical & Biotechnology Companies  Diagnostic Laboratories  Company Profiles Agilent Technologies, Inc.  Business Description  Financial Information (Subject to data availability)  Shimadzu Corporation  Thermo Fisher Scientific, Inc.  Waters Corporation  Product Portfolio  News Coverage  Bio-Rad Laboratories, Inc.  Bruker Corporation  Danaher Corporation 

3. Illumina, Inc.  Merck KGaA  PerkinElmer, Inc.  Get Sample Copy Of This Research Study: https://www.credenceresearch.com/sample-request/59694 Reuters: https://www.reuters.com/brandfeatures/venture-capital/article?id=109990 Market Watch: https://www.marketwatch.com/press-release/life-science-instrumentation-market-65-cagr- 2018-2026-global-business-growth-size-analysis-2019-09-13 About Us Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.